Crossbeta Biosciences completes financing round and appoints Guus Scheefhals as CEO
14-Apr-2010 -
Crossbeta Biosciences announced that it has successfully completed a financing round of up to Eur 2 million, which is funded by new as well as existing shareholders and also includes an Innovation Grant from SenterNovem. The financing will be used to further advance Crossbeta’s technology in ...
DSM
Fresenius
Pharmaceutics